72 results
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
targets may occur may change. Such changes may have a material impact on the assessment of the expected cash flows of the CVRs.
Amryt reviews
6-K
EX-99.5
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
may have a material impact on the assessment of the expected cash flows of the CVRs.
Amryt reviews the expected cash flows on a regular basis
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
5:06pm
and the assessment process by EMA was completed on April 22, 2022, when the Committee for Medician Products for Human Use (“CHMP”) adopted a positive … to management’s assessment of our internal control over financial reporting;
not being required to comply with any requirement that may be adopted
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:58pm
, 2021 and the assessment process by EMA was completed on April 22, 2022, when the Committee for Medician Products for Human Use (“CHMP”) adopted
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:57pm
Application for Oleogel-S10 for the treatment of Dystrophic EB (“DEB”) and Junctional EB (“JEB”) was validated by EMA on March 25, 2021 and the assessment
F-3
nlcf jmfj9x
11 May 22
Shelf registration (foreign)
5:22pm
POS AM
0h2ht5yqdsp rk1ffhr9
11 May 22
Prospectus update (post-effective amendment)
5:20pm
POS AM
85s8kltd2g84
11 May 22
Prospectus update (post-effective amendment)
5:19pm
424B3
20vn nh6fefnobt962gj
4 May 22
Prospectus supplement
8:35am
424B3
eyb9w rci0m5e
4 May 22
Prospectus supplement
7:45am
6-K
EX-99.1
cix yivx41lvjznt
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
424B3
cd8vif6by9730
31 Mar 22
Prospectus supplement
8:44am
424B3
6rjp rqp3w
31 Mar 22
Prospectus supplement
8:44am
6-K
EX-99.3
e95mkd5qh
31 Mar 22
Results of General Meeting
8:41am
424B3
toipe
9 Mar 22
Prospectus supplement
9:26am
424B3
aka1bc9t mk3cqg9
9 Mar 22
Prospectus supplement
9:25am
6-K
EX-99.1
erfhkra phmuyzr
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am